Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis

Research and Reports in Urology

Volumn 8, Issue , 2016, Pages 77-84

  Lee, Hak J ^a   Yousefi, Kasra ^b   Haddad, Zaid ^b   Abdollah, Firas ^c   Lam, Lucia L C ^b   Shin, Heesun ^b   Alshalalfa, Mohammed ^b   Godebu, Elana ^a   Wang, Song ^d   Shabaik, Ahmed ^e   Davicioni, Elai ^b   Kane, Christopher J ^a  

^a USA   (United States)

^b GenomeDx Biosciences Inc   (Canada)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biopsy; Decipher; Genomic classifier; Lymph node invasion; Prognosis; Prostate; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; COHORT ANALYSIS; DECIPHER TEST; GENOME ANALYSIS; GLEASON SCORE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROSTATECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; TUMOR INVASION;

EID: 84992735573     PISSN: None     EISSN: 22532447     Source Type: Journal    
DOI: 10.2147/RRU.S99997     Document Type: Article

References (15)

1. Boström PJ, Bjartell AS, Catto JWF, et al. Genomic predictors of outcome in prostate cancer. Eur Urol. 2015; 68(6): 1033-1044. doi:10.1016/j.eururo.2015.04.008.
2. Ross AE, D’Amico AV, Freedland SJ. Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer. Prostate Cancer Prostatic Dis. Epub 2015 Jun 30. doi:10.1038/pcan.2015.31.
3. Erho N, Crisan A, Vergara IA, et al. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS One. 2013; 8(6): e66855. doi:10.1371/journal.pone.0066855.
4. Karnes RJ, Bergstralh EJ, Davicioni E, et al. Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. J Urol. 2013; 190(6): 2047-2053. doi:10.1016/j.juro.2013.06.017.
5. Den RB, Feng FY, Showalter TN, et al. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy. Int J Radiat Oncol Biol Phys. 2014; 89(5): 1038-1046. doi:10.1016/j.ijrobp.2014.04.052.
6. Ross AE, Feng FY, Ghadessi M, et al. A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Prostate Cancer Prostatic Dis. 2014; 17(1): 64-69. doi:10.1038/pcan.2013.49.
7. Klein EA, Yousefi K, Haddad Z, et al. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy. Eur Urol. 2015; 67(4): 778-786. doi:10.1016/j.eururo.2014.10.036.
8. Den RB, Yousefi K, Trabulsi EJ, et al. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy. J Clin Oncol. 2015; 33(8): 944-951. doi:10.1200/JCO.2014.59.0026.
9. Ross AE, Johnson MH, Yousefi K, et al. Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate- and high-risk men. Eur Urol. 2016; 69(1): 157-165. doi:10.1016/j.eururo.2015.05.042.
10. Klein EA, Haddad Z, Yousefi K, et al. Decipher genomic classifier measured on prostate biopsy predicts metastasis risk. Urology. Epub 2016 Jan 22. doi:10.1016/j.urology.2016.01.012.
11. Freedland SJ, Choeurng V, Howard L, et al. Utilization of a genomic classifier for prediction of metastasis following salvage radiation therapy after radical prostatectomy. Eur Urol. Epub 2016 Jan 21. doi:10.1016/j.eururo.2016.01.008.
12. Yamoah K, Johnson MH, Choeurng V, et al. Novel biomarker signature that may predict aggressive disease in African American men with prostate cancer. J Clin Oncol. 2015; 33(25): 2789-2796. doi:10.1200/JCO.2014.59.8912.
13. Glass AG, Leo MC, Haddad Z, et al. Validation of a genomic classifier for predicting post-prostatectomy recurrence in a community-based healthcare setting. J Urol. Epub 2015 Nov 25. doi:10.1016/j.juro.2015.11.044.
14. Choeurng V, Luo B, Yousefi K, et al. Re-calibration of genomic risk prediction models in prostate cancer to improve individual-level predictions. In: Joint Statistical Meeting; August 8-13, 2015; Seattle, Washington.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476): 307-310.